| Authors: |
Valentin JP; Early Clinical Development & Translational Science, Non-Clinical Safety Evaluation, UCB, Braine L'Alleud, Belgium. Electronic address: jean-pierre.valentin@ucb.com., Bourcier T; Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.; Todd Bourcier Current Contact Information is 'White Oak Regulatory Tox, LLC, Crownsville, MD 21032, USA.. Electronic address: todd.bourcier@whiteoakregtox.com., Chi X; Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.. Electronic address: Xuan.Chi@fda.hhs.gov., Delaunois A; Early Clinical Development & Translational Science, Non-Clinical Safety Evaluation, UCB, Braine L'Alleud, Belgium. Electronic address: annie.delaunois@ucb.com., Foley CM; Preclinical Safety/Safety Pharmacology, AbbVie Inc., North Chicago, IL 60064, USA.. Electronic address: michael.foley@abbvie.com., Henderson KA; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA 91320, USA.. Electronic address: khende02@amgen.com., Lainee P; Sanofi Research and Development, Translational Models, Montpellier, France.. Electronic address: pierre.lainee@sanofi.com., Leishman DJ; Drug Disposition, Toxicology and PKPD, Eli Lilly and Company, Indianapolis, IN 46285, USA.. Electronic address: derek.leishman@lilly.com., Li D; Pfizer Research and Development, Eastern Point Road, Groton, CT 06340, USA.. Electronic address: dingzhou.li@pfizer.com., Pawluk E; Early Clinical Development & Translational Science, Non-Clinical Safety Evaluation, UCB, Braine L'Alleud, Belgium. Electronic address: emma.pawluk@ucb.com., Pugsley MK; Cytokinetics, Toxicology & Safety Pharmacology, South San Francisco, CA 85024, USA.. Electronic address: mpugsley@cytokinetics.com., Rajamani S; Johnson & Johnson Innovative Medicine, 3120 Merryfield Row, San Diego, CA 92121, USA.. Electronic address: srajama3@its.jnj.com., Regan CP; Nonclinical Drug Safety Merck & Co., Inc., Rahway, NJ 07065, USA.. Electronic address: christopher_regan@merck.com., Rolf MG; AstraZeneca R&D, Pepparedsleden 1, 431 83 Mölndal, Sweden. Electronic address: mike.rolf@astrazeneca.com., Ross R; Labcorp, Madison, WI 53704, USA.. Electronic address: rebecca.ross@labcorp.com., Rossman EI; GSK, Safety Pharmacology, Collegeville, PA 19426, USA.. Electronic address: eric.i.rossman@gsk.com., Tichenor SD; Charles River Laboratories, 6995 Longley Lane, Reno, NV 89511, USA.. Electronic address: steve.tichenor@crl.com., Villar IC; AstraZeneca R&D, The Discovery Centre, 1 Francis Crick Avenue, Cambridge CB20AA, UK. Electronic address: conchi.villarmoas@astrazeneca.com., Wisialowski TA; Pfizer Research and Development, Eastern Point Road, Groton, CT 06340, USA.. Electronic address: todd.a.wisialowski@pfizer.com., Wu J; Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.. Electronic address: jean.wu@fda.hhs.gov., Vargas HM; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA 91320, USA.. Electronic address: hvargas@amgen.com. |
